No Data
No Data
No Data
Lirum Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Lirum Therapeutics, Inc (NASDAQ:LRTX) IPO will take place May, 10 on the NASDAQ exchange under the ticker LRTX.The company is offering shares at an expected price between $10.00 and $12.00 per share
Lirum Therapeutics Expects to Sell 2.27M Shares in IPO
Lirum Therapeutics expects to sell 2.27 million shares in its initial public offering.
Lirum Therapeutics to Present Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy Demonstrating Potent Preclinical Activity Against Adult and Pediatric IGF-Related Cancers, at the 2024 AACR Annual Meeting
New York, NY, April 04, 2024 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (Lirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today the upcoming
Lirum Therapeutics Files for Proposed $25M IPO
Oncology drug developer Lirum Therapeutics (LRTX) has filed for a proposed $25M initial public offering.
No Data